SMTL ID : 4bxk.2 (1 other biounit)

Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with a domain-specific inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: N.45, T.47, E.49, N.50 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)

NAG-NAG-BMA.2: 4 residues within 4Å: Chain A: N.416, E.522, P.524, Q.527 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.522

2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.3: 2 residues within 4Å: Chain A: W.335 Ligands: 1IU.7 No protein-ligand interaction detected (PLIP) PEG.6: 3 residues within 4Å: Chain A: V.296, I.408 Ligands: P6G.5 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.408

1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.4: 4 residues within 4Å: Chain A: R.453, D.462, Y.465, L.466 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.453 Water bridges: A:Q.444

1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)

P6G.5: 6 residues within 4Å: Chain A: Q.286, G.287, W.288, H.292, R.295 Ligands: PEG.6 No protein-ligand interaction detected (PLIP)

1 x 1IU: [3-[[(2S)-1-azanyl-1-oxidanylidene-propan-2-yl]amino]-2-methyl-3-oxidanylidene-propyl]-[(1R)-1-[[(2R)-2-azanyl-3-(1H-1,2,3,4-tetrazol-5-yl)propanoyl]amino]-2-phenyl-ethyl]phosphinic acid(Post Translational Modification)

1IU.7: 20 residues within 4Å: Chain A: Q.259, H.331, A.332, S.333, A.334, H.361, E.362, H.365, Y.369, H.388, E.389, F.435, K.489, F.490, H.491, T.496, Y.498, Y.501 Ligands: PEG.3, ZN.9 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.435, A:F.490, A:F.490, A:T.496, A:Y.501 Hydrogen bonds: A:Q.259, A:A.334, A:A.334, A:Y.369, A:Y.369, A:K.489, A:K.489 Water bridges: A:G.382, A:E.389, A:Y.501 pi-Cation interactions: A:H.388

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.8: 3 residues within 4Å: Chain A: N.480, T.482, H.483 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.482, A:T.482

1 x ZN: ZINC ION(Non-covalent)

ZN.9: 4 residues within 4Å: Chain A: H.361, H.365, E.389 Ligands: 1IU.7 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.361, A:H.365, A:E.389

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.10: 5 residues within 4Å: Chain A: Y.202, P.385, P.497, I.499, R.500 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Douglas, R.G. et al., Fragment-Based Design for the Development of N-Domain Selective Angiotensin-1 Converting Enzyme Inhibitors. Clin.Sci. (2014)

Release Date

2013-09-18

Peptides

ANGIOTENSIN-CONVERTING ENZYME: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

ANGIOTENSIN-CONVERTING ENZYME

Related Entries With Identical Sequence